Victory Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Victory Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-45,120	Closed	-$215K	–	2786
2022 Q1	$215K	Sell	45,120 -77,854	-63%	-$282K	﹤0.01%	2394
2021 Q4	$439K	Buy	122,974 +8,326	+7%	+$29.1K	﹤0.01%	2216
2021 Q3	$417K	Buy	114,648 +29,219	+34%	+$118K	﹤0.01%	2262
2021 Q2	$372K	Buy	85,429 +5,255	+7%	+$21.4K	﹤0.01%	2342
2021 Q1	$330K	Buy	80,174 +4,175	+5%	+$18.1K	﹤0.01%	2363
2020 Q4	$303K	Buy	75,999 +20,586	+37%	+$66.6K	﹤0.01%	2282
2020 Q3	$150K	Buy	55,413 +30,916	+126%	+$85.6K	﹤0.01%	2317
2020 Q2	$67K	Sell	24,497 -25,267	-51%	-$70.5K	﹤0.01%	2381
2020 Q1	$118K	Buy	49,764 +16,254	+49%	+$55.3K	﹤0.01%	2493
2019 Q4	$157K	Buy	33,510 +7,449	+29%	+$30.5K	﹤0.01%	2381
2019 Q3	$87K	Buy	+26,061	New	+$85.8K	﹤0.01%	2483

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Victory Capital Management's ATRS Position: Q2 2022 in Review

Victory Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 45,120 shares — an estimated $215K sold.

Victory Capital Management first reported a position in ATRS in Q3 2019 and held it in 11 quarters. The position peaked at $439K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Victory Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Victory Capital Management sold 45,120 Antares Pharma, Inc. shares in Q2 2022, an estimated $215K.
Victory Capital Management first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 11 quarters.
Victory Capital Management's Antares Pharma, Inc. position peaked at $439K in Q4 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.